Mode
Text Size
Log in / Sign up
N/A N=15 Treatment

The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures

Mechanical Ventilation · Airway Patency · Respiratory Depression

Enrolled (actual)
15
Serious AEs
0.0%
Results posted
May 2026
Primary outcome: Primary: Inspiratory Airflow — 0.36; 0.47; 0.44 L/s

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Subanesthetic ketamine (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Massachusetts General Hospital
Primary completion
Dec 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Inspiratory Airflow
0.36; 0.47; 0.44
SECONDARY
EEG Beta-gamma Power
2.9; 4.2
SECONDARY
Minute Ventilation
6.95; 8.24; 8.33
SECONDARY
Tidal Volume
0.29; 0.39; 0.39
SECONDARY
Work of Breathing
0.6; 0.4; 0.4
SECONDARY
Inspiratory Airway Resistance
17.7; 15.1; 9.1
SECONDARY
Lung Compliance
23; 20; 26

Summary

Impairment of airway patency is a common cause of extubation failure and opioids and hypnotics can adversely affect airway patency. Ketamine, a noncompetitive antagonist of N-methyl-D-aspartate (NMDA), unlike other anesthetics activates respiratory effort and promotes bronchodilation. At subanesthetic plasma concentration, ketamine reduces both opioid and propofol requirements. The purpose of this pharmaco-physiological interaction trial is to evaluate the effects of ketamine on breathing and electroencephalography in mechanically ventilated patients.

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years admitted to ICU requiring mechanical ventilation
  • Suitable for spontaneous breathing trial
  • Candidate to received low dose ketamine by the primary critical care team

Exclusion Criteria

  • Esophageal injury
  • Allergic to ketamine
  • Known neurodegenerative disorders
  • Major neurologic disorders (elevated ICP)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01969227). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search